23. Prevalence and factors associated with COVID-19 vaccination coverage among hospitalized patients infected with SARS-COV-2 in Bac Ninh and Nghe An, Vietnam, 2022
Main Article Content
Abstract
A cross-sectional study was conducted to describe the prevalence of COVID-19 vaccination coverage and explore factors associated with non-vaccination among patients hospitalized due to SARS-CoV-2 infection at Bac Ninh Provincial General Hospital and Nghe An Provincial Huu Nghi General Hospital in the first six months of 2022 in Vietnam. Among 3.242 hospitalized patients, the percentage of patients who have received at least two doses of the COVID-19 vaccine was 60.6%, and 30.1% of patients had not been vaccinated. AstraZeneca and Pfizer were the two most commonly and early administered vaccines, and 25.1% of people had heterologous vaccines. Females, people 60 years of age or older, retired workers or students, and people with chronic cardiovascular or chronic lung diseases had a significantly higher likelihood of not getting vaccinated against COVID-19 than other groups. Therefore, diverse and comprehensive interventions are needed to address the problem of unsatisfactory vaccine coverage rates to achieve community immunity in vulnerable groups and limit clinical consequences such as recurrence, severe progression, or death.
Article Details
Keywords
SARS-CoV-2, COVID-19, hospitalized patient, vaccination coverage, non-vaccination, Vietnam
References
2. Lotfi H, Mazar MG, Ei NMH, Fahim M, Yazdi NS. Vaccination is the most effective and best way to avoid the disease of COVID-19. Immun Inflamm Dis. Aug 2023; 11(8): e946. doi:10.1002/iid3.946.
3. World Health Organization. Coronavirus disease (COVID-19): Vaccines and vaccine safety. Accessed Dec 31, 2023. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/covid-19-vaccines.
4. Andrews N, Stowe J, Kirsebom F, et al. Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant. N Engl J Med. Apr 21 2022; 386(16): 1532-1546. doi:10.1056/NEJMoa2119451.
5. Chemaitelly H, Tang P, Hasan MR, et al. Waning of BNT162b2 Vaccine Protection against SARS-CoV-2 Infection in Qatar. N Engl J Med. Dec 9 2021; 385(24): e83. doi:10.1056/NEJMoa2114114.
6. Embi PJ, Levy ME, Naleway AL, et al. Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021. MMWR Morb Mortal Wkly Rep. Nov 5 2021; 70(44): 1553-1559. doi:10.15585/mmwr.mm7044e3.
7. Tenforde MW, Olson SM, Self WH, et al. Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years - United States, January-March 2021. MMWR Morb Mortal Wkly Rep. May 7 2021; 70(18): 674-679. doi:10.15585/mmwr.mm7018e1.
8. Thompson MG, Stenehjem E, Grannis S, et al. Effectiveness of Covid-19 Vaccines in Ambulatory and Inpatient Care Settings. N Engl J Med. Oct 7 2021; 385(15): 1355-1371. doi:10.1056/NEJMoa2110362.
9. Tregoning JS, Flight KE, Higham SL, Wang Z, Pierce BF. Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape. Nat Rev Immunol. Oct 2021; 21(10): 626-636. doi:10.1038/s41577-021-00592-1.
10. Zhu K, Ma S, Chen H, et al. Factors associated with COVID-19 vaccination coverage in hypertensive patients with Omicron infection in Shanghai, China. Hum Vaccin Immunother. Aug 2023; 19(2): 2253599. doi:10.1080/21645515.2023.2253599.
11. Quyết định số 165/QĐ - BYT của Bộ Y Tế về Kế hoạch phòng, chống dịch bệnh truyền nhiễm ban hành ngày 21/01/2022.
12. Bộ Y Tế. Cổng thông tin của Bộ Y Tế về đại dịch COVID-19 - Vaccine tiêm phòng bệnh. Accessed Dec 31, 2023. https://covid19.gov.vn/vaccine-tiem-chung.htm.
13. Nhu HV, Tuyet-Hanh TT, Quang N, Linh TNQ, Tien TQ. COVID-19 Vaccine Acceptance in Vietnam: An Online Cross-Sectional Study. Asia Pac J Public Health. Jan 2022; 34(1): 131-133. doi:10.1177/10105395211053732.
14. Tran L, Dang T, Nguyen M, et al. Behavioural and social drivers of COVID-19 vaccination in Vietnam: a scoping review. BMJ Open. Dec 21 2023; 13(12): e081134. doi:10.1136/bmjopen-2023-081134.
15. Nghị quyết số 128/NQ - CP của Chính phủ về quy định tạm thời “Thích ứng an toàn, linh hoạt, kiểm soát hiệu quả dịch COVID-19” ban hành ngày 11/10/2021.
16. Công văn số 10722/BYT - DP của Bộ Y Tế về Hướng dẫn tiêm vắc xin phòng COVID-19 ban hành ngày 17/12/2021.
17. Freeman D, Loe BS, Chadwick A, et al. COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II. Psychol Med. Oct 2022; 52(14): 3127-3141. doi:10.1017/s0033291720005188.
18. Goddard K, Hanson KE, Lewis N, Weintraub E, Fireman B, Klein NP. Incidence of Myocarditis/Pericarditis Following mRNA COVID-19 Vaccination Among Children and Younger Adults in the United States. Ann Intern Med. Dec 2022; 175(12): 1169-1771. doi:10.7326/m22-2274.
19. Heidecker B, Dagan N, Balicer R, et al. Myocarditis following COVID-19 vaccine: incidence, presentation, diagnosis, pathophysiology, therapy, and outcomes put into perspective. A clinical consensus document supported by the Heart Failure Association of the European Society of Cardiology (ESC) and the ESC Working Group on Myocardial and Pericardial Diseases. Eur J Heart Fail. Nov 2022; 24(11): 2000-2018. doi:10.1002/ejhf.2669.